Results of the cooperative protocol (N-III-95) for metastatic relapses and refractory neuroblastoma

Medical and Pediatric Oncology

Volumn 35, Issue 6, 2000, Pages 724-726

  Castel, V ^a   Canete A ^a   Melero, C ^a   Acha, T ^a   Navajas, A ^a   Garcia Miguel P ^a   Contra, T ^a   Molina, J ^a   Galaron P ^a   Cruz, O ^a  

^a HOSPITAL INFANTIL LA FE   (Spain)

Author keywords

Continuous infusion chemotherapy; MIBG; Neuroblastoma; Relapse

Indexed keywords

(3 IODOBENZYL)GUANIDINE;

BONE MARROW METASTASIS; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HEMATOLOGIC DISEASE; HUMAN; INFANT; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

3-IODOBENZYLGUANIDINE; ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEUROBLASTOMA; SURVIVAL RATE;

EID: 0033660015     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-911X(20001201)35:6<724::AID-MPO53>3.0.CO;2-U     Document Type: Conference Paper

References (8)

1. Combined continuous infusion etoposide with high-dose cyclophosphamide for refractory neuroblastoma: A phase II study from the Societe Francaise d'Oncologie Pediatrique
2. Escalating dose of continuous infusion combination chemotherapy for refractory neuroblastoma
3. Chemotherapy for patients with recurrent or refractory neuroblastoma: A POG phase II study
4. 131-metaiodobenzylguanidine (MIBG) in neuroblastoma: A phase II study in nine patients
5. Treatment of neuroblastoma with metaiodobenzylguanidine: Results and side effects
6. 131-I-metaiodobenzylguanidine treatment in patients with refractory advanced neuroblastoma
7. International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma
8. Protocol N-II-92 for high risk patients with neuroblastoma